HRP20201673A1 - Local antiseptic solution for sensitive skin and mucous membrane - Google Patents
Local antiseptic solution for sensitive skin and mucous membrane Download PDFInfo
- Publication number
- HRP20201673A1 HRP20201673A1 HRP20201673AA HRP20201673A HRP20201673A1 HR P20201673 A1 HRP20201673 A1 HR P20201673A1 HR P20201673A A HRP20201673A A HR P20201673AA HR P20201673 A HRP20201673 A HR P20201673A HR P20201673 A1 HRP20201673 A1 HR P20201673A1
- Authority
- HR
- Croatia
- Prior art keywords
- solution
- sensitive skin
- mucous membranes
- infections
- antiseptic solution
- Prior art date
Links
- 210000004400 mucous membrane Anatomy 0.000 title claims abstract description 23
- 230000002421 anti-septic effect Effects 0.000 title claims abstract description 20
- 230000037307 sensitive skin Effects 0.000 title claims abstract description 17
- 208000015181 infectious disease Diseases 0.000 claims abstract description 23
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 claims abstract description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 6
- 230000003187 abdominal effect Effects 0.000 claims abstract description 5
- 239000000443 aerosol Substances 0.000 claims abstract description 5
- 239000013543 active substance Substances 0.000 claims abstract description 4
- 210000002345 respiratory system Anatomy 0.000 claims description 6
- 230000002485 urinary effect Effects 0.000 claims description 6
- 241000701806 Human papillomavirus Species 0.000 claims description 3
- 206010046914 Vaginal infection Diseases 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 238000005868 electrolysis reaction Methods 0.000 claims 1
- 239000002324 mouth wash Substances 0.000 claims 1
- 229940051866 mouthwash Drugs 0.000 claims 1
- 229940100662 nasal drops Drugs 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 210000001635 urinary tract Anatomy 0.000 abstract description 6
- 206010057190 Respiratory tract infections Diseases 0.000 abstract description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract description 3
- 230000009931 harmful effect Effects 0.000 abstract description 3
- 244000005700 microbiome Species 0.000 abstract description 3
- 208000020029 respiratory tract infectious disease Diseases 0.000 abstract description 3
- 229910052708 sodium Inorganic materials 0.000 abstract description 3
- 239000011734 sodium Substances 0.000 abstract description 3
- 230000001839 systemic circulation Effects 0.000 abstract description 3
- 229940064004 antiseptic throat preparations Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 231100000676 disease causative agent Toxicity 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002574 cystoscopy Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002289 effect on microbe Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Otopina lokalni antiseptik za osjetljivu kožu i sluznice koristi se za prevenciju i liječenje infekcija raznih etiologija. Djelatna supstanca je atomski kisik koncentracije 75 do 95 mg na jedan litar otopine koji se oslobađa iz labilne veze natrium-oksiklorita (hipoklorita). Vrlo efikasno uništava sve vrste mikroorganizama, a pritom ne djeluje štetno na površine na kojima se primjenjuje. Ne resorbira se i ne dospijeva u sistemsku cirkulaciju. Može se preventivno i terapeutski koristiti za vaginalna i abdominalna ispiranja, ispiranje mokraćnih kanala i kao kapi i aerosol za inhalaciju kod infekcija respiratornih puteva.A local antiseptic solution for sensitive skin and mucous membranes is used to prevent and treat infections of various aetiologies. The active substance is atomic oxygen with a concentration of 75 to 95 mg per litre of solution released from the labile bond of sodium oxychlorite (hypochlorite). It very effectively destroys all types of microorganisms, while not having a harmful effect on the surfaces on which it is applied. It is not resorbed and does not enter the systemic circulation. It can be used preventively and therapeutically for vaginal and abdominal rinsing, urinary tract rinsing and as drops and aerosol for inhalation in respiratory tract infections.A local antiseptic solution for sensitive skin and mucous membranes is used to prevent and treat infections of various etiologies. The active substance is atomic oxygen with a concentration of 75 to 95 mg per liter of solution released from the labile bond of sodium oxychlorite (hypochlorite). It very effectively destroys all types of microorganisms, while not having a harmful effect on the surfaces on which it is applied. It is not resorbed and does not enter the systemic circulation. It can be used preventively and therapeutically for vaginal and abdominal rinsing, urinary tract rinsing and as drops and aerosol for inhalation in respiratory tract infections. A local antiseptic solution for sensitive skin and mucous membranes is used to prevent and treat infections of various aetiologies. The active substance is atomic oxygen with a concentration of 75 to 95 mg per liter of solution released from the labile bond of sodium oxychlorite (hypochlorite). It very effectively destroys all types of microorganisms, while not having a harmful effect on the surfaces on which it is applied. It is not resorbed and does not enter the systemic circulation. It can be used preventively and therapeutically for vaginal and abdominal rinsing, urinary tract rinsing and as drops and aerosol for inhalation in respiratory tract infections.
Description
Područje na koje se izum odnosi The field to which the invention relates
Ovaj izum se odnosi na otopinu u grupi pripravaka za medicinsku i stomatološku primjenu koja sadrži aktivne neorganske sastojke, prema međunarodnoj klasifikaciji (MKP) klasificiranu kao: A61 K 33/00; 33/14, a prema terapijskom djelovanju kemijskih spojeva ili medicinskih pripravaka, prema međunarodnoj klasifikaciji (MKP) klasificiranu u grupi antiinfektivnih lijekova, lokalnih antiseptika kao: A 61 P 31/00; 31/02, za primjenu na lokalizacijama: mokraćni kanali, vaginalna, abdominalna, oralna, nazalna i ostali dišni putovi. This invention relates to a solution in the group of preparations for medical and dental use that contains active inorganic ingredients, according to the international classification (MKP) classified as: A61 K 33/00; 33/14, and according to the therapeutic effect of chemical compounds or medical preparations, according to the international classification (ICD) classified in the group of anti-infective drugs, local antiseptics as: A 61 P 31/00; 31/02, for application on localizations: urinary canals, vaginal, abdominal, oral, nasal and other respiratory tracts.
Tehnički problem Technical problem
Kod tretiranja infekcija osjetljive kože, sluznice i rane postoji veliki problem u odabiru lokalnog antiseptika za suzbijanje uzročnika infekcije. Dosadašnji lokalni antiseptici koji se koriste za ovu namjenu imaju taj nedostatak, da u koliko dobro djeluju na uzročnika infekcije, nepovoljno djeluju na sluznice na kojima se primjenjuju, odnosno, ako ne oštećuju sluznice onda su slabo učinkoviti na uzročnike infekcije. Sluznica peritoneuma je vrlo osjetljiva na lokalne antiseptike i kod pojave infekcije u trbušnoj šupljini, za ispiranje se koristi fiziološka otopina sa kojom se samo mehanički ispire abdomen. Kod vaginalnih infekcija razne etiologije, zbog osjetljivosti sluznice, dosadašnji lokalni antiseptici su vrlo neefikasni, a protiv nekih uzročnika infekcije i potpuno neučinkoviti (Humani papilloma virus). Ista je situacija kod vršenja transuretralnih intervencija. Kada se cistoskop ubacuje u mokraćni kanal, infekciju sa početka mokraćnog kanala cistoskop mehanički prenese u dubinu kanala. Kod dijagnostičkih i terapeutskih intervencija na mokraćnim kanalima cistoskop (ili kamenac koji je već u kanalu), mehanički može oštetiti sluznicu mokraćnog kanala i postoji opasnost od pojave infekcije. Prilikom cistoskopije, za permanentno ispiranje mokraćnih kanala koristi se isključivo sterilna voda koja samo mehanički ispire mokraćne putove. Kod infekcije respiratornih putova ne postoji sredstvo, lokalni antiseptik koji djeluje na uzročnika infekcije, pogotovo na virusne infekcije koje su najčešći uzrok. When treating infections of sensitive skin, mucous membranes and wounds, there is a big problem in choosing a local antiseptic to combat the cause of the infection. Current local antiseptics used for this purpose have the disadvantage that as much as they work well on the causative agent of the infection, they have an unfavorable effect on the mucous membranes on which they are applied, that is, if they do not damage the mucous membranes, then they are poorly effective on the causative agents of the infection. The mucous membrane of the peritoneum is very sensitive to local antiseptics, and in the event of an infection in the abdominal cavity, a physiological solution is used for rinsing, with which the abdomen is only washed mechanically. In the case of vaginal infections of various etiologies, due to the sensitivity of the mucous membrane, current local antiseptics are very ineffective, and completely ineffective against some causative agents of infection (human papilloma virus). The situation is the same when performing transurethral interventions. When the cystoscope is inserted into the urinary canal, the infection from the beginning of the urinary canal is mechanically transferred by the cystoscope to the depth of the canal. During diagnostic and therapeutic interventions on the urinary canals, a cystoscope (or a stone already in the canal) can mechanically damage the mucous membrane of the urinary canal and there is a risk of infection. During cystoscopy, only sterile water is used for permanent flushing of the urinary tract, which only mechanically flushes the urinary tract. In the case of respiratory tract infection, there is no agent, a local antiseptic that acts on the cause of the infection, especially on viral infections, which are the most common cause.
Izlaganje biti izuma Presentation of the essence of the invention
Primarni cilj izuma je primjena otopine lokalni antiseptik za suzbijanje infekcije na osjetljivoj koži i sluznici, koja vrlo efikasno uništava sve vrste uzročnika infekcije: viruse, bakterije i gljivice, a pritom ne oštećuje površine na kojima se primjenjuje. The primary goal of the invention is the application of a local antiseptic solution to combat infection on sensitive skin and mucous membranes, which very efficiently destroys all types of infectious agents: viruses, bacteria and fungi, while not damaging the surfaces on which it is applied.
Djelatna supstanca otopine je atomski kisik koji nastaje kao posljedica labilne veze u molekuli natrium-oksiklorita (hipoklorita). Koncentracija kisika u otopini je od 75 do 95 mg na jedan litar otopine. The active substance of the solution is atomic oxygen, which is formed as a result of a labile bond in the sodium oxychlorite (hypochlorite) molecule. The concentration of oxygen in the solution is from 75 to 95 mg per one liter of solution.
Otopina lokalni antiseptik za osjetljivu kožu, sluznice i rane vrlo efikasno uništava sve vrste mikroorganizama: bakterije, viruse, gljivice i spore. The local antiseptic solution for sensitive skin, mucous membranes and wounds very effectively destroys all types of microorganisms: bacteria, viruses, fungi and spores.
Namjenski pripremljena otopina ne sadrži nikakve štetne supstance i ne nadražuje osjetljive površine na kojima se primjenjuje. Otopina ima razorno djelovanje na mikroorganizme i uginula i raspadnuta tkiva pretvarajući ih u netoksične spojeve. Djeluje na površinske dijelove i ne dospijeva u sistemsku cirkulaciju. Otopina nije otrovna i raspada se na neotrovne elemente. The specially prepared solution does not contain any harmful substances and does not irritate the sensitive surfaces on which it is applied. The solution has a devastating effect on microorganisms and dead and decomposed tissues, turning them into non-toxic compounds. It acts on the surface parts and does not reach the systemic circulation. The solution is non-toxic and decomposes into non-toxic elements.
Opis načina ostvarivanja izuma Description of the method of realization of the invention
Otopina lokalni antiseptik za osjetljivu kožu i sluznice može se primjenjivati kod svih vrsta infekcija na osjetljivoj koži i sluznici. Kod vaginalnih infekcija otopina se koristi za vaginalna ispiranja i tamponiranja. Preventivno se može koristiti kod svih vrsta vaginalnih intervencija i operativnih zahvata prije, za vrijeme i poslije zahvata. Local antiseptic solution for sensitive skin and mucous membranes can be used for all types of infections on sensitive skin and mucous membranes. In case of vaginal infections, the solution is used for vaginal washings and tampons. It can be used preventively in all types of vaginal interventions and surgical procedures before, during and after the procedure.
Kod citoskopskih transuretralnih dijagnostičkih i terapeutskih intervencija otopina za osjetljivu kožu i sluznice može se koristiti za prevenciju i suzbijanje infekcije u mokraćnim kanalima. In cytoscopic transurethral diagnostic and therapeutic interventions, the solution for sensitive skin and mucous membranes can be used to prevent and control infection in the urinary tract.
Kod abdominalnih zahvata, kada postoji opasnost od infekcije ili je ona već prisutna (otvaranje crijeva, perforacija žučne kese, perforacija slijepog crijeva i sl.) otopinom za osjetljivu kožu i sluznice se može vršiti ispiranje abdominalne šupljine. In abdominal procedures, when there is a risk of infection or it is already present (opening of the intestine, perforation of the gallbladder, perforation of the appendix, etc.), the abdominal cavity can be rinsed with a solution for sensitive skin and mucous membranes.
Kod infekcija respiratornih puteva razne etiologije otopina za osjetljivu kožu i sluznice služi za suzbijanje infekcije ispiranjem usta i grla, kao kapi i sprej za nosnu šupljinu i kao aerosol za inhaliranje za suzbijanje infekcije na ostalim dijelovima respiratornog sistema. In case of respiratory tract infections of various etiologies, the solution for sensitive skin and mucous membranes is used to control infection by rinsing the mouth and throat, as drops and spray for the nasal cavity and as an aerosol for inhalation to control infection in other parts of the respiratory system.
Način primjene izuma Method of application of the invention
Otopina za osjetljivu kožu i sluznice primjenjuje se kao lokalni antiseptik na inficirane površine, u vidu otopine kojom se površina ispire, tamponira ili se stavljaju obloge od gaze natopljene otopinom. Kod infekcija respiratornih puteva otopina se koristi za ispiranje usta i grla, kao kapi za nos i u vidu aerosola za inhalaciju za tretiranje infekcija na ostalim dijelovima respiratornog sistema. Vrijeme ekspozicije je od 1 do 15 minuta i duže. Vrijeme trajanja terapije je od 5 do 20 dana i duže, odnosno do nestanka simptoma bolesti. Kod infekcija mokraćnih kanala i transuretralnih intervencija vrši se ispiranje mokraćnih kanala. The solution for sensitive skin and mucous membranes is applied as a local antiseptic to infected surfaces, in the form of a solution with which the surface is washed, tamponed, or gauze dressings soaked in the solution are applied. In case of infections of the respiratory tract, the solution is used for rinsing the mouth and throat, as drops for the nose and in the form of an aerosol for inhalation to treat infections in other parts of the respiratory system. The exposure time is from 1 to 15 minutes and longer. The duration of the therapy is from 5 to 20 days or longer, that is, until the symptoms of the disease disappear. In the case of urinary tract infections and transurethral interventions, urinary tract irrigation is performed.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HRP20201673AA HRP20201673A1 (en) | 2020-10-19 | 2020-10-19 | Local antiseptic solution for sensitive skin and mucous membrane |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HRP20201673AA HRP20201673A1 (en) | 2020-10-19 | 2020-10-19 | Local antiseptic solution for sensitive skin and mucous membrane |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20201673A1 true HRP20201673A1 (en) | 2022-04-29 |
Family
ID=81291996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20201673AA HRP20201673A1 (en) | 2020-10-19 | 2020-10-19 | Local antiseptic solution for sensitive skin and mucous membrane |
Country Status (1)
| Country | Link |
|---|---|
| HR (1) | HRP20201673A1 (en) |
-
2020
- 2020-10-19 HR HRP20201673AA patent/HRP20201673A1/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11033517B2 (en) | Materials and methods for controlling infections | |
| Engelman et al. | Mediastinitis following open-heart surgery: review of two years' experience | |
| JP5912218B2 (en) | Antibacterial extracellular polysaccharide solvation system | |
| US20210154158A1 (en) | Devices, methods, and compositions for controlling infections | |
| BRPI0721044A2 (en) | DEVICES AND METHODS FOR DISTRIBUTING TARGET-ACTIVE AGENTS | |
| RU2566066C1 (en) | Method for integrated drug processing of root canal of tooth | |
| CN108926577A (en) | A kind of method that electric potential water is used for Wound antibiotic healing cleaning-nursing | |
| HRP20201673A1 (en) | Local antiseptic solution for sensitive skin and mucous membrane | |
| RU2662925C1 (en) | Method of treatment of adenorinosinusitis | |
| CA2778081A1 (en) | Devices, methods, and composition for controlling infections | |
| Keen | Military Surgery in 1861 and in 1918 | |
| RU2281098C1 (en) | Method for treatment of chronic tonsillitis decompensated form | |
| Fleming | Semmelweis Commemoration: Puerperal Fever: The Historical Development of its Treatment | |
| RU2478345C1 (en) | Method of surgical treatment of multilocular echinococcosis of liver | |
| RU2296570C2 (en) | Method for treating suppurant residual hepatic cavities after echinococcectomy | |
| RU2540512C1 (en) | Method for integrated drug-induced treatment of root canal | |
| RU2761032C1 (en) | Method for preparing the surgical area before performing endonasal intervention on the tear ducts | |
| RU2371154C1 (en) | Method of chronic purulent medium otitis treatment in reconstruction of middle ear deformities | |
| Calik et al. | Histopathological examination of the impact of sodium hypochlorite on the hepatobiliary system. An experimental study | |
| Reddish et al. | MERCUROCHROME-220 SOLUBLE AND USP TINCTURE OF IODINE: COMPARISON OF GERMICIDAL EFFICIENCY IN SKIN DISINFECTION | |
| CN108210514A (en) | Wound irrigation liquid | |
| RU2290937C1 (en) | Method for arresting nasal hemorrhages | |
| RU2679919C2 (en) | Therapeutic elixir for irrigation of the maxillary sinus mucosa in case of oroanthral inosculation | |
| RU2593785C2 (en) | Method of maturated liver residual cavity treating after echinococcectomy | |
| RU2188633C2 (en) | Method for treating burns and thermochemical injuries of respiratory tract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| OBST | Application withdrawn |